Both CRISPR Therapeutics and Wave Life Sciences operate within the medical/biomedical industry.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both CRISPR Therapeutics and Wave Life Sciences operate within the medical/biomedical industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CRISPR Therapeutics
company in Basel, Switzerland
Nothing else this week.
-
Wave Life Sciences
biotechnology company
Nothing else this week.
Related events
- CRISPR Therapeutics, Eli Lilly, and Johnson & Johnson are noted as major holdings in health care ETFs.
- CRISPR Therapeutics and Vertex Pharmaceuticals split profits and costs for Casgevy, while CRISPR plans to present pipeline data at the AHA meeting.
- CRISPR Therapeutics formed a strategic partnership with Vertex Pharmaceuticals.
- CRISPR Therapeutics presented clinical data at the American Society of Hematology meeting on November 4, 2026.
- Orna Therapeutics was acquired by Eli Lilly and Company, a development within the RNA therapeutics sector.
Coverage
Newest first; wire copies grouped- ZacksCRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last? CRISPR Therapeutics AG CRSP shares rallied 9.6% in the last trading session to close at $60.08. This move can be attributable to